Subscribe to our Newsletters !!
In tortoises, longevity is an astonishing trait. N
Eppendorf today announced the worldwide sales star
Dr. Mohammed Enayat’s recent testimony on his ag
This year, the Hamburg based life sciences company
Cipla Limited (BSE: 5
Since it’s an ingredient in so many foods, you h
Welcome to the latest issue of Microbioz India. As
Eppendorf today announced the worldwide sales start of its next generation of mechanical pipettes, the Eppendorf Research® 3 neo. The new pipettes offer renowned Eppendorf accuracy and precision, faster or easier volume selection, optimized ergonomics with a shorter pipetting button, and adaptable settings and accessories to customize the pipetting experience for speed, comfort, or accuracy in different applications.
The new pipettes are available for sale in India since August 5, 2025. The Research 3 neo pipette is highly adaptable, allowing users to easily speed up or fine-tune volume changes by switching between two volume setting speeds. Users can also temporarily adjust the pipette to accommodate different liquid types, tip geometries, reverse pipetting, and altitudes, ensuring optimal accuracy across various applications without the need for recalibration. Additionally, the new ColorTag changeable pipette marking rings 1) enable users to reversibly label the instrument.
Further adding to its customization options, the Research 3 neo boasts carefully designed ergonomics. Features include a new operating concept with a shorter pipetting button, an ergonomic finger hook, and a well- balanced, lightweight design. Additionally, it offers low tip attachment and ejection forces, ensuring comfortable and efficient use.
Like all Eppendorf pipettes, the Research 3 neo places accuracy and precision at its core. Constructed from high-quality materials and subjected to extensive testing, this mechanical air-cushion pipette delivers performance beyond ISO 8655 test limits, when paired with epT.I.P.S.® pipette tips. The new volume lock feature facilitates care-free pipetting as unintentional volume changes are prevented.
Commenting on the launch of the Research 3 neo pipette, Christiane Markau (Product Innovation Manager at Eppendorf SE) said, “We’re extremely proud to introduce the latest generation of mechanical pipettes, the Research 3 neo. Our mission has been to create a pipette that is the perfect fit for all users, in terms of its adaptability and accessories, as well as its comfort and performance.”
Last but not least, the Research 3 neo is at the forefront of pipetting sustainability. This durable, long-lasting pipette is manufactured in an ISO 14001 certified plant powered with 100 % renewable energy and features an ACT® label, highlighting Eppendorf’s commitment to eco-friendlier production and products. The pipette comes in recycled and recyclable packs and is compatible with the innovative epT.I.P.S.® BioBased pipette tips made of 100 % biobased polypropylene according to mass-balance approach*, helping to lower the carbon footprint of labs using them.
1) sold separately, learn more at www.eppendorf.link/colortag
Learn more about Research 3 neo pipettes at www.eppendorf.link/research3neo
*Learn more about epT.I.P.S.® BioBased and mass-balance approach at www.eppendorf.link/biobased
Learn more about the ACT® label at https://act.mygreenlab.org
Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world.
The product portfolio of the business units Liquid Handling & Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2024, the Eppendorf Group recorded consolidated revenue of €980.3 million and invested €69 million in research and development (R&D).
Eppendorf products are used in academic or industrial research laboratories, such as pharmaceutical, biotech, chemical, and food industries, as well as clinical, environmental, forensic, and industrial laboratories for process analysis, production, and quality assurance.
Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in more than 30 countries. Today, the Group employs around 4,500 people worldwide. They all act in accordance with the purpose of the company’s founders: to improve human living conditions.
